Phase II Study of Growth Hormone in Children With Cystic Fibrosis

Inclusion Criteria

• •PROTOCOL ENTRY CRITERIA:
• •-Disease Characteristics--
• •Diagnosis of prepubertal cystic fibrosis
• •No colonization by Burkholderia cepacia
• •-Prior/Concurrent Therapy--
• •No prior or concurrent insulin requirement
• •-Patient Characteristics--
• •Hematopoietic: No hematologic disease
• •Hepatic: No liver disease
• •Renal: No kidney disease
• •Pulmonary: Must be able to perform pulmonary function testing
• •Other: No history of diabetes Must be less than 25% of normal height and/or weight for age and sex